Development and Validation of a Predictive Nomogram for Myelosuppression Risk in Chronic Hepatitis B Patients Treated with Peginterferon
{{output}}
Purpose: Peginterferon (Peg-IFN) is a common treatment for chronic hepatitis B (CHB); however, some patients developing myelosuppression as a side-effect. In this study, we identified risk factors associated with increased myelos... ...
